A randomized, double-blind, placebo-controlled, study evaluating the efficacy of dfn-02 (nasal spray of sumatriptan 10 mg + permeation enhancer) in migraine with or without aura

Authors
Category Primary study
JournalNeurology
Year 2018
This article has no abstract
Epistemonikos ID: 0a7612a5678e1dc74620b207e33255f17569ed32
First added on: Feb 09, 2025